T Wave Alternans in Hemodialysis

Indiana University30 enrolled

Overview

The purpose of this study is to determine if the hemodialysis procedure changes the risk for cardiac arrest in patients.

One-third to one-quarter of hemodialysis patients die of sudden cardiac death (SCD). The hemodialysis procedure may theoretically increase the risk of SCD. This study uses T wave alternans, a noninvasive marker of SCD, to objectively determine whether the hemodialysis procedure alters the risk of SCD in hemodialysis patients.

Study Type

OBSERVATIONAL

Enrollment

Conditions

End Stage Renal Disease Coronary Heart Disease Congestive Heart Failure

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years of age or older * Normal sinus rhythm Exclusion Criteria: * Inability to give written informed consent * Active cardiac ischemia * Pacemaker * Inability to perform a brief walking treadmill test

Locations (1)

Indiana University School of Medicine

Indianapolis, Indiana, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.